CAMH, Dr. David Gratzer: Physician and Educator at the Centre for Addiction and Mental Health
newmedia@camh.ca (Dr. Mahavir Agarwal, Lisa Schaffer, Dr. Sanjeev Sockalingam, Dr. David Gratzer)
The semaglutide era? Considering medication-related weight gain
The semaglutide era? Considering medication-related weight gain
The semaglutide era? Considering medication-related weight gain
Wednesday 16th July 2025
Explore semaglutide's potential in mental health care with Dr. Gratzer and experts. A deep dive into medication-related weight gain.
32 minutes
Informative
Hopeful
Compassionate
Educational
Supportive
About this podcast
Author:
CAMH, Dr. David Gratzer: Physician and Educator at the Centre for Addiction and Mental Health
Overview:
Categories:
Body & Mind
Innovative Treatments & Recovery Paths
Mindfulness & Technology in Health
Mindful Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
55 (View all)
Do you want to link to this podcast?
Get the buttons here!Semaglutide: A New Hope for Managing Medication-Induced Weight Gain
Episode Overview
- Semaglutide offers potential in managing weight gain caused by antipsychotic medications.
- Access to GLP-1 medications remains a significant challenge for many patients.
- Obesity should be treated as a chronic disease requiring comprehensive care.
- Stigma around obesity needs to be addressed through open conversations.
- Long-term implications of using these medications are still being explored.
"Imagine this world where you have all the effects of antipsychotics, but none of the side effects."
In this episode of 'Quick Takes', Dr. David Gratzer dives into the fascinating world of semaglutide and other GLP-1 medications, exploring their role in managing medication-related weight gain in mental health patients. With expert guests Dr. Mahavir Agarwal, Lisa Schaffer, and Dr. Sanjeev Sockalingam, the conversation navigates the promising potential and challenges of these treatments. The episode sheds light on how these medications could be a game-changer for patients struggling with obesity due to antipsychotic medications. Dr.
Agarwal shares his cautious optimism, discussing the opportunities these drugs present in managing metabolic side effects effectively. Meanwhile, Dr. Sockalingam highlights the access issues that patients face, especially those on social assistance or precariously housed. Lisa Schaffer brings a unique perspective from her lived experience, stressing the need for broader conversations around obesity as a chronic disease requiring a continuum of care. The trio also touches upon the stigma surrounding obesity and the need for courageous conversations in clinical settings.
As they unpack the complexities of prescribing these medications, the discussion turns to the long-term implications and unanswered questions surrounding their use. This episode is a must-listen for anyone interested in the intersection of mental health, medication, and weight management. So, if you're curious about how these 'forever drugs' might reshape treatment landscapes, tune in for an engaging and informative dialogue.